comprehensive -WSS

comprehensive

author：explore 2025-09-29 09:04:28 Page View：382

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： With competition flaring, obesity drug hits goal in liver disease study
Next article： Activists slam private health insurers over coverage restrictions

leisure time

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Precocious puberty in girls comes with mental health risks

MollyFergusonforSTATZariawasjust9yearsoldwhenanursepractitionerdeliverednewsthatrockedherworld:Theyo

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

In his State of the Union, Biden takes clear aim at 'Big Pharma'

PresidentBidendeliverstheStateoftheUnionaddresstoajointsessionofCongressattheU.S.CapitolonThursday.A

comprehensive

focus

leisure time

In his State of the Union, Biden takes clear aim at 'Big Pharma'